MedPath

Ayurvedic treatment for Cerebral palsy

Phase 3
Recruiting
Conditions
Patients diagnosed with cerebral palsy
Registration Number
CTRI/2015/09/006207
Lead Sponsor
IPGTRA GAU Jamnagar
Brief Summary

This  is randomised clinical trial  to study Management of cerebral palsy with chaturbhadra kalpa basti and yoga basti.In group A 3 seatings of chaturbhadra kalpa bast iwith an interval of 14 days  and in group B 3 seatings of yoga  basti with an interval of 14 days will be done.In both the groups Medhya churna will be taken as an internal medicine through out the treatment schedule with anupana madhu.Follow up period is 2 months for both the groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 1.Diagnosed Children of C.P. of either sex, of 6 months to 10yrs of age.
  • 2.Children with developmental disability both either physical or mental, in mild or moderate degree as compared to other normal children.
Exclusion Criteria
  • 1.Children of age < 6 months and > 10 yrs.
  • 2.Children of C.P. with major congenital disorder and other disease status viz.
  • Juvenile Diabetes, Acute infections etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lower down the spasticitylower down the spasticity | increse in muscle power improvement in general health
increse in muscle power improvement in general healthlower down the spasticity | increse in muscle power improvement in general health
Secondary Outcome Measures
NameTimeMethod
Enhance the quality of life of cerebral palsy childEnhance the quality of life of cerebral palsy child and reduce the burden on parents

Trial Locations

Locations (1)

PG Hospital IPGTRA JAMNAGAR

🇮🇳

Jamnagar, GUJARAT, India

PG Hospital IPGTRA JAMNAGAR
🇮🇳Jamnagar, GUJARAT, India
Dr V K Kori
Principal investigator
9374548475
drvkkori@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.